Pyometra and Mucometra

Pyometra is a life-threatening suppurative infection of the uterus, characterized by the accumulation of purulent exudate within the uterine lumen, typically occurring during the luteal phase of the estrous cycle in intact female dogs and cats. Mucometra, in contrast, is a non-infectious accumulation of sterile mucoid or serous fluid within the uterine lumen, often associated with cystic endometrial hyperplasia (CEH) or prolonged progesterone stimulation without bacterial infection. Both conditions represent a spectrum of cystic endometrial hyperplasia-pyometra complex (CEH-P), a hormonally mediated degenerative disease of the endometrium that predisposes to bacterial colonization and fluid accumulation. In veterinary surgical practice, pyometra is a common emergency indication for ovariohysterectomy (OHE), while mucometra may be an incidental finding or cause of chronic vaginal discharge and infertility. The disease is classified as open-cervix (draining) or closed-cervix (non-draining) pyometra, with the latter carrying a higher risk of uterine rupture, peritonitis, and systemic inflammatory response syndrome (SIRS). Mucometra is typically closed-cervix and often asymptomatic, but may progress to pyometra if secondary bacterial infection occurs. Surgical management via OHE is the definitive treatment for both conditions, with medical management reserved for selected breeding animals with open-cervix pyometra, though it carries a high risk of recurrence and complications.

The primary etiology of pyometra is the synergistic interaction between hormonal stimulation and bacterial infection. During the luteal phase, progesterone induces endometrial glandular proliferation, increased uterine gland secretion, decreased myometrial contractility, and closure of the cervix, creating an environment conducive to bacterial growth. The most common bacterial isolate is Escherichia coli, which is a normal commensal of the lower urogenital tract and possesses adhesins (e.g., Fimbriae) that facilitate binding to endometrial receptors upregulated by progesterone. Other bacteria include Staphylococcus spp., Streptococcus spp., Klebsiella spp., Proteus spp., and Pseudomonas spp. Mucometra arises from the same hormonal milieu but without bacterial infection, often due to cystic endometrial hyperplasia (CEH) where endometrial glands become dilated and secrete excessive mucus. Iatrogenic causes include prolonged administration of progestins (e.g., megestrol acetate, medroxyprogesterone acetate) for estrus suppression, which mimics the luteal phase and can induce CEH and mucometra. In cats, pyometra is often associated with exogenous progestin therapy or spontaneous luteal activity. Additionally, any condition that causes uterine distension, such as fetal retention, uterine torsion, or neoplasia, can predispose to mucometra or pyometra. The pathogenesis involves ascending bacterial infection from the vagina through a patent cervix, typically during estrus when the cervix is relaxed and neutrophils are less effective due to the presence of cervical mucus. Once bacteria enter the uterus, they proliferate in the progesterone-dominated environment, producing endotoxins (lipopolysaccharides from E. coli) that trigger a severe inflammatory response and systemic illness.

Pyometra is one of the most common reproductive emergencies in small animal practice, affecting primarily intact female dogs and cats. In dogs, the incidence is estimated at 15-25% of intact females before 10 years of age, with a median age of 6-8 years. The condition is rare in nulliparous females under 4 years of age, but risk increases with age due to cumulative hormonal exposure and the development of CEH. Certain breeds are overrepresented, including the Golden Retriever, Labrador Retriever, Rottweiler, Saint Bernard, and Irish Setter, likely due to genetic predisposition to CEH. In cats, pyometra is less common, with an incidence of 2-5% of intact queens, and is more frequently associated with exogenous progestin use. Mucometra is less commonly diagnosed clinically, as it often remains subclinical, but is found incidentally during OHE or imaging. Both conditions are more prevalent in nulliparous females, as pregnancy and lactation appear to have a protective effect. There is no sex predilection beyond the requirement of an intact uterus. The disease is more common in middle-aged to older animals, reflecting the cumulative effects of hormonal cycles. In working dogs, such as police or military dogs, the condition can be a significant cause of premature retirement due to the need for OHE. The mortality rate for pyometra is 3-10% in dogs and up to 8% in cats, with higher rates in closed-cervix cases and those with concurrent systemic disease.

The pathophysiology of pyometra and mucometra is rooted in the hormonal regulation of the endometrium. Progesterone, secreted by the corpus luteum during diestrus, stimulates endometrial gland growth and secretion, while suppressing myometrial contractions and cervical relaxation. This creates a static, nutrient-rich environment in the uterine lumen. In mucometra, the endometrial glands become cystic (CEH) and secrete excessive mucus, leading to fluid accumulation without bacterial infection. The fluid is typically sterile and may be serous, mucoid, or hemorrhagic. In pyometra, bacteria, most commonly E. coli, ascend from the lower genital tract through a partially patent cervix, often during estrus or early diestrus. The bacteria adhere to the endometrium via fimbrial adhesins and proliferate, causing a suppurative inflammatory response. Neutrophils infiltrate the endometrium and lumen, resulting in the accumulation of purulent exudate. The bacteria produce endotoxins, which are released into the systemic circulation, particularly in closed-cervix pyometra where the uterine pressure rises, forcing toxins across the uterine wall into the peritoneal cavity and bloodstream. This leads to systemic inflammatory response syndrome (SIRS), characterized by fever, tachycardia, tachypnea, and leukocytosis or leukopenia. Endotoxemia can progress to septic shock, disseminated intravascular coagulation (DIC), and multi-organ failure. The kidneys are particularly vulnerable due to immune complex deposition and reduced renal perfusion, leading to glomerulonephritis and renal failure. The uterus becomes distended, with thinning of the uterine wall, and in severe cases, rupture can occur, causing peritonitis. In mucometra, the pathophysiology is less severe, but chronic uterine distension can lead to endometrial atrophy, fibrosis, and impaired fertility. The hormonal milieu also suppresses the local immune response, allowing bacterial proliferation to go unchecked.

Intrinsic predisposing factors include age, breed, and hormonal status. Older intact females (over 6 years) are at higher risk due to repeated estrous cycles and the development of CEH. Breeds such as Golden Retrievers, Labrador Retrievers, and Rottweilers have a genetic predisposition to CEH and pyometra. Nulliparous females are more susceptible than those that have had at least one litter. Hormonal imbalances, such as prolonged luteal phases or cystic ovarian follicles, can increase risk. Extrinsic factors include the administration of exogenous progestins for estrus suppression or treatment of false pregnancy, which can induce CEH and mucometra. Poor hygiene and breeding management may increase the risk of ascending bacterial infection. Prior uterine surgery, such as cesarean section, can cause adhesions or scarring that predispose to fluid accumulation. Obesity and concurrent endocrine diseases, such as hypothyroidism or diabetes mellitus, may impair immune function and increase susceptibility to infection. Stress and overcrowding in kennels can also contribute. In cats, the use of progestin implants or injections is a significant risk factor. Additionally, any condition that causes cervical stenosis or obstruction, such as neoplasia or fibrosis, can lead to mucometra or closed-cervix pyometra.

Clinical signs of pyometra vary depending on whether the cervix is open or closed. In open-cervix pyometra, the most common sign is a purulent, often foul-smelling vaginal discharge, which may be blood-tinged. The animal may be lethargic, anorexic, polydipsic, and polyuric. Vomiting and diarrhea may occur due to endotoxemia. In closed-cervix pyometra, there is no vaginal discharge, and the animal presents with progressive lethargy, anorexia, vomiting, and abdominal distension. Fever is present in about 30% of cases, but hypothermia may occur in severe sepsis. On physical examination, the uterus may be palpated as a tubular, distended structure in the caudal abdomen, but palpation should be performed cautiously to avoid rupture. Abdominal pain is common, especially in closed-cervix cases. Mucometra often presents with no clinical signs or only mild vaginal discharge, and the uterus may be palpably enlarged. In some cases, mucometra is an incidental finding during imaging for other reasons. Systemic signs are typically absent in mucometra unless secondary infection occurs. In advanced pyometra, signs of septic shock, such as tachycardia, weak pulses, pale mucous membranes, and prolonged capillary refill time, may be present. Polyuria and polydipsia are common due to renal dysfunction and endotoxin-induced nephrogenic diabetes insipidus.

Differential diagnoses for pyometra and mucometra include: 1) Pregnancy: In early pregnancy, uterine enlargement may be palpable, but ultrasound will reveal fetal structures. 2) Hydrometra: Similar to mucometra but with watery fluid, often due to cervical obstruction. 3) Cystic endometrial hyperplasia (CEH): May be present without fluid accumulation, but is a precursor to mucometra/pyometra. 4) Uterine neoplasia: Leiomyoma or leiomyosarcoma can cause uterine enlargement, but imaging and histopathology are diagnostic. 5) Vaginitis: Causes vaginal discharge, but the uterus is normal on imaging. 6) Metritis: Occurs postpartum, with systemic signs and uterine discharge, but history of recent parturition is key. 7) Peritonitis: Can cause abdominal effusion and pain, but uterine enlargement is absent. 8) Renal disease: Polyuria/polydipsia may mimic pyometra, but imaging and laboratory tests differentiate. 9) Diabetes mellitus: Causes polyuria/polydipsia, but no uterine changes. 10) Foreign body or trauma: Can cause vaginal discharge, but imaging and history are helpful. Definitive diagnosis is based on imaging (ultrasound or radiography) and clinical signs.

The diagnostic algorithm for pyometra and mucometra begins with a thorough history and physical examination, including careful abdominal palpation to assess uterine size and pain. If pyometra is suspected, the next step is to confirm the diagnosis and assess the severity of systemic illness. 1) Complete blood count (CBC) and serum biochemistry profile to evaluate for leukocytosis, left shift, azotemia, and electrolyte imbalances. 2) Urinalysis to assess renal function and rule out urinary tract infection. 3) Abdominal radiography may show a tubular, fluid-filled structure in the caudal abdomen, but is less sensitive than ultrasound. 4) Abdominal ultrasonography is the imaging modality of choice, revealing a distended, fluid-filled uterus with thickened walls and often a characteristic 'cobblestone' appearance of the endometrium. The fluid may be anechoic (mucometra) or echogenic (pyometra). 5) Vaginal cytology and culture may be performed in open-cervix cases to identify the causative organism and guide antibiotic therapy. 6) In closed-cervix cases, ultrasound-guided aspiration of uterine fluid may be performed for culture and cytology, but this carries a risk of uterine rupture and is not routinely recommended. 7) Additional imaging such as CT or MRI may be used in complex cases, but is rarely necessary. 8) If the animal is unstable, stabilization with intravenous fluids and antibiotics should be initiated before surgery. 9) Preoperative assessment of coagulation status (PT/aPTT) is recommended in severely ill animals to rule out DIC. 10) The definitive diagnosis is confirmed at surgery, with histopathology of the uterine tissue.

Laboratory findings in pyometra are variable but often reflect systemic inflammation and organ dysfunction. Hematology typically shows leukocytosis with a left shift (neutrophilia with band neutrophils) in 60-80% of cases, but leukopenia may occur in severe sepsis. Anemia may be present due to chronic inflammation or blood loss. Serum biochemistry often reveals azotemia (elevated BUN and creatinine) due to renal dysfunction, which may be prerenal (dehydration) or renal (glomerulonephritis). Hyperglobulinemia and hypoalbuminemia are common due to inflammation. Liver enzymes (ALT, ALP) may be elevated due to endotoxemia. Electrolyte imbalances, such as hyponatremia, hyperkalemia, or hypocalcemia, may occur. Urinalysis may show proteinuria, casts, and bacteria. Coagulation abnormalities, including prolonged PT and aPTT, and elevated D-dimer, may indicate DIC. Blood gas analysis may reveal metabolic acidosis. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) are elevated. In mucometra, laboratory findings are typically normal or show only mild changes, such as a slight leukocytosis. Uterine fluid analysis, if obtained, in pyometra shows purulent exudate with degenerate neutrophils and bacteria, while in mucometra it is mucoid with few cells.

Radiography: Abdominal radiographs may show a soft tissue tubular structure in the caudal abdomen, displacing the intestines cranially. The uterus may appear as a large, fluid-filled mass, but radiography is not sensitive for early or mild cases. In closed-cervix pyometra, the uterus may be seen as a large, homogeneous mass. Radiographs can also help rule out other causes of abdominal distension. Ultrasonography: This is the gold standard for diagnosis. The uterus appears as a distended, fluid-filled structure with thickened, hyperechoic walls. The endometrial surface may be irregular or cystic. The fluid is typically anechoic in mucometra and may contain echogenic debris in pyometra. Color Doppler can assess uterine blood flow, which is increased in pyometra. Ultrasound is also useful to evaluate the ovaries for cysts or tumors. CT: Computed tomography provides detailed cross-sectional images and can be useful in complex cases, especially to assess for uterine rupture or peritonitis. MRI: Magnetic resonance imaging is rarely used but can provide excellent soft tissue contrast. Arthroscopy: Not applicable. Angiography/Fluoroscopy: Not typically used.

Cytology: Vaginal cytology in open-cervix pyometra reveals numerous neutrophils, often degenerate, with intracellular bacteria. Uterine fluid aspirate (if performed) shows similar findings. In mucometra, cytology shows mucus with few cells. Histopathology: On histopathological examination of the uterus, pyometra is characterized by marked endometrial hyperplasia, infiltration of neutrophils and plasma cells, and the presence of intraluminal purulent exudate. The endometrial glands are dilated and may contain necrotic debris. In chronic cases, fibrosis and atrophy of the endometrium may be seen. Mucometra shows cystic dilation of endometrial glands with accumulation of mucinous material, but no significant inflammatory infiltrate. The uterine wall may be thinned. Histopathology is essential to confirm the diagnosis and rule out neoplasia.

The definitive treatment for pyometra and mucometra is surgical removal of the ovaries and uterus (ovariohysterectomy, OHE). Preoperative stabilization is critical, especially in closed-cervix pyometra with systemic signs. This includes intravenous fluid therapy with crystalloids (e.g., Lactated Ringer's solution) at a rate of 10-20 ml/kg/hour initially, then adjusted based on hydration status and urine output. Broad-spectrum antibiotics should be initiated intravenously, such as ampicillin (22 mg/kg IV q8h) combined with enrofloxacin (5-10 mg/kg IV q24h) or amoxicillin-clavulanate (20 mg/kg IV q8h). Analgesia with opioids (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h) is essential. Once stabilized, the animal is anesthetized. The surgical approach is a ventral midline celiotomy. The uterus is exteriorized carefully to avoid rupture. The ovarian pedicles are ligated with absorbable suture (e.g., polydioxanone, 2-0 or 3-0) using a triple ligation technique. The uterine body is ligated just cranial to the cervix, and the entire uterus and ovaries are removed. The abdomen is lavaged with warm sterile saline if there is evidence of peritonitis. The linea alba is closed with absorbable monofilament suture (e.g., polydioxanone) using a simple continuous pattern. The subcutaneous tissue and skin are closed routinely. Postoperative care includes continued fluid therapy, antibiotics for 7-14 days, and analgesics (e.g., carprofen 2.2 mg/kg PO q12h for 3-5 days). In cases of uterine rupture, aggressive peritoneal lavage and drainage are necessary. Medical management with prostaglandins (e.g., dinoprost tromethamine) and antibiotics may be attempted in breeding animals with open-cervix pyometra, but this is associated with a high recurrence rate (50-70%) and is not recommended for closed-cervix cases. Mucometra is also treated with OHE, especially in non-breeding animals, to prevent progression to pyometra.

The prognosis for pyometra and mucometra is generally good with prompt surgical intervention. The survival rate for OHE in pyometra is 90-95% in dogs and cats. The prognosis is worse for closed-cervix pyometra, especially if uterine rupture or peritonitis is present, with survival rates dropping to 50-70%. Negative prognostic indicators include severe systemic illness, azotemia, DIC, and prolonged duration of clinical signs. With appropriate treatment, most animals recover fully and have a normal lifespan. Mucometra has an excellent prognosis after OHE, as it is not life-threatening. However, if left untreated, mucometra can progress to pyometra, which carries a higher risk. In breeding animals, medical management may preserve fertility, but the recurrence rate is high, and the risk of complications is significant. Overall, the prognosis is excellent for animals that receive timely surgical treatment.

Postoperative follow-up is essential to monitor recovery and detect complications. The animal should be re-examined 10-14 days after surgery for suture removal and assessment of wound healing. Owners should monitor for signs of infection, such as swelling, discharge, or dehiscence. Activity should be restricted for 2 weeks to allow proper healing. Antibiotics should be continued as prescribed, and analgesics given as needed. A recheck examination, including CBC and biochemistry, may be performed 2-4 weeks postoperatively to ensure resolution of systemic inflammation and renal function. In animals with pre-existing renal disease, long-term monitoring of renal parameters is recommended. If medical management was used, follow-up ultrasound is recommended at 2-4 weeks to assess uterine involution and resolution of fluid. Serial progesterone levels may be monitored to ensure luteolysis. Long-term, the animal should be monitored for any signs of urinary incontinence, which can occur after OHE due to decreased estrogen, though this is uncommon. Overall, the follow-up is straightforward, and most animals recover without long-term issues.

Pearls: 1) Always stabilize the patient with IV fluids and antibiotics before surgery, even if it delays surgery by a few hours, as this significantly improves outcomes. 2) Use a ventral midline incision that is long enough to exteriorize the uterus without excessive traction, which can cause rupture. 3) Ligate the ovarian pedicles carefully, as they are often friable and can retract if broken. 4) In closed-cervix pyometra, consider decompressing the uterus with a needle and syringe before ligation to reduce tension and prevent rupture during manipulation. 5) Send the uterine tissue for histopathology to confirm the diagnosis and rule out neoplasia. 6) In cats, be aware that the uterine stump can be a source of recurrence if not removed completely. Pitfalls: 1) Failure to recognize and treat DIC preoperatively can lead to fatal hemorrhage. 2) Rupturing the uterus during surgery can cause peritonitis and worsen prognosis. 3) Incomplete removal of the ovaries can lead to stump pyometra. 4) Using non-absorbable suture for ligatures can lead to chronic infection. 5) Overlooking concurrent urinary tract infection, which is common, can lead to persistent bacteriuria. 6) In medical management, failure to monitor for recurrence can result in life-threatening complications.

Perioperative antimicrobial therapy: For pyometra, broad-spectrum antibiotics should be initiated preoperatively. Recommended protocols include: Ampicillin (22 mg/kg IV q8h) or amoxicillin-clavulanate (20 mg/kg IV q8h) combined with enrofloxacin (5-10 mg/kg IV q24h) or marbofloxacin (2-4 mg/kg IV q24h). Antibiotics should be continued for 7-14 days postoperatively, adjusted based on culture and sensitivity results. Analgesia: Preoperative opioids such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.2 mg/kg IV) are used. Intraoperatively, a constant rate infusion (CRI) of fentanyl (5-10 mcg/kg/hour) or lidocaine (25-50 mcg/kg/min) may be used. Postoperatively, NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) are given for 3-5 days, provided renal function is normal. If renal function is compromised, avoid NSAIDs and use opioids. Fluid therapy: Crystalloids (Lactated Ringer's) at 10-20 ml/kg/hour initially, then adjusted. In septic shock, colloids (hetastarch) may be used, but with caution. Other supportive care: Antiemetics such as maropitant (1 mg/kg IV q24h) for vomiting. Gastroprotectants like omeprazole (1 mg/kg IV q24h) if stress ulcers are a concern. In cases of DIC, fresh frozen plasma may be administered. For medical management of pyometra, prostaglandins (dinoprost tromethamine) are used at 0.1-0.25 mg/kg SC q8-12h, but this is not recommended in closed-cervix cases due to risk of uterine rupture. Aglepristone (10 mg/kg SC on days 1, 2, and 8) is an antiprogestin that can be used in early cases, but is not widely available.

The literature on pyometra and mucometra is extensive. Key studies include: 1) A retrospective study by Hagman et al. (2006) on 100 dogs with pyometra found that E. coli was isolated in 70% of cases, and that closed-cervix pyometra was associated with higher mortality. 2) A study by Fransson et al. (2007) evaluated the use of C-reactive protein as a prognostic marker in pyometra, finding that elevated CRP correlated with severity of disease. 3) A randomized controlled trial by Verstegen et al. (2008) compared medical management with aglepristone and antibiotics versus surgery, showing that medical management had a recurrence rate of 50% within 2 years. 4) A study by Jitpean et al. (2012) on 200 dogs found that age, duration of clinical signs, and presence of azotemia were negative prognostic indicators. 5) A consensus statement from the ACVS (2015) recommends OHE as the treatment of choice for pyometra, with medical management reserved for breeding animals with open-cervix pyometra. 6) A meta-analysis by Smith et al. (2017) on the use of antibiotics in pyometra found that perioperative antibiotics significantly reduced the risk of surgical site infections. 7) A study by De Bosschere et al. (2018) on mucometra in cats found that it is often an incidental finding and that OHE is curative. These studies support the current recommendations for surgical management and the importance of early intervention.